You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. NuCana to Present Data on NUC-7738's Synergy with PD-1 Inhibitors at the ESMO Congress 2025
- 2. Case report: Curative effect and mechanism of surufatinib combined with toripalimab in the treatment of 1 case of lung large-cell neuroendocrine carcinoma
- 3. Study identifies key features of cancer cell response and resistance to treatment
- 4. Molecular test personalises prostate cancer treatment
- 5. Potential application of nanodelivery systems targeting ELAVL1 in prostate cancer treatment
- 6. Case Report: Genomic insights into prostate adenocarcinoma transdifferentiation to carcinosarcoma due to lineage plasticity
- 7. Challenges and breakthroughs: current landscape and future prospects of CAR-T cell therapy clinical trials for solid tumors
- 8. "This Is How We Do It" Star Montell Jordan Opens Up About His Prostate Cancer Journey As Part of Powerful New Partnership with ZERO Prostate Cancer
- 9. Deep learning in breast cancer risk prediction: a review of recent applications in full-field digital mammography
- 10. Key parameters in intratumoral-peritumoral region fusion models: optimizing deep learning radiomics for breast cancer diagnosis
Last updated at 11:10 GMT
Hot News Makers
Health/Pharma Companies
-
67542.48
-
30373.75
-
19724.90
-
18726.16
-
16845.53
-
5859.90
-
5767.60
-
5285.63
-
5004.37
-
4512.83
Drugs, Treatments, Trials
-
10421.66
-
8124.69
-
6750.15
-
5734.43
-
2192.94
-
1713.76
-
1342.08
-
1318.27
-
811.07
-
699.49
Last updated at 10:10 GMT
